Poster Session: Poster Session 2
Sunday May 05, 2019 from 18:30 to 19:30
Exhibit-Poster Area

Refreshments will be served


Session Supported by

Poster Discussants
  • P.200 Risk Factors for Diabetes after Pediatric Kidney Transplant
    Tom Blydt-Hansen, Canada
  • P.201 Predictive value of renal resistive index in paediatric renal transplantation
    Miss Saima Azam, United Kingdom
  • P.202 Paired kidney exchange: kidney transplant of a pediatric patient hypersensitized, first experience in Mexico
    Dr. Lucino Bahena Carrera, Mexico
  • P.203 High intrapatient variability of calcineurin inhibitor levels is associated with post-transplant diabetes mellitus in pediatric kidney transplant
    Dr. Lucino Bahena Carrera, Mexico
  • P.204 Lower urinary tract dysfunction is still underestimated in pediatric kidney transplants despite underlying cause of renal failure
    Dr. Charlotte M. Bootsma-Robroeks, Netherlands
  • P.205 Post-renal transplant thrombotic microangiopathy in a patient with recurrent henoch-schönlein purpura nephritis and terminal ileitis
    Mrs. Paula S. Bresso Jr., Argentina
  • P.206 Expansion of Remote Laboratory Monitoring to Include Everolimus and Creatinine in Pediatric Transplant Population
    Dr. Jane A Dickerson, United States
  • P.207 Early transplantation in a small anuric infant on dialysis
    Ms. Jill Farquhar, Australia
  • P.208 Combined treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after kidney transplantation
    Dr. Yuko Hamasaki, Japan
  • P.209 Co-produced Videos to Improve Knowledge Among Caregivers of Children with a Kidney Transplant
    Dr. David K. Hooper, United States
  • P.210 The Role of Liver Transplantation in the treatment of Atypical Haemolytic Uraemic Syndrome (aHUS) in countries where Eculizumab is not available
    Dr. Mignon McCulloch, South Africa
  • P.211 Combined liver and kidney transplant - Are we ready to break the odds and go for a uniform consensus?
    Dr. Evgenia Preka, United Kingdom
  • P.213 Prevalence of Blood Pressure Control in Children with Kidney Transplant in the Improving Renal Outcomes Collaborative (IROC)
    Dr. Pamela D Winterberg, United States
  • P.214 CMV Viremia and Development of CMV-Specific Cytotoxic T-cells (CMV-Tc) in Pediatric Renal Transplant Recipients
    Prof. Mohammad H Malekzadeh, United States
  • P.215 Isolated Pre-Transplant Angiotensin II Type I Receptor Antibodies (AT1R Ab) are Not Associated with Reduced Graft Function or Hypertension (HTN) in Pediatric Kidney Transplant (Ped KTx) Patients (pts)
    Prof. Mohammad H Malekzadeh, United States
  • P.220 Use of DCD Livers in Pediatric Recipients: Outcomes in High vs. Low Volume Centers
    Dr. Amal Aqul, United States
  • P.221 Pediatric living donor liver transplantation from adult allograft liver after resection of focal nodular hyperplasia
    Dr. Nuttapon Arpornsujaritkun, Thailand
  • P.222 JCV Progressive Multifocal Leukoencephalopathy presenting as acute sensorineural hearing loss in an intestinal transplant patient
    Mrs. Julie A Iglesias, United States
  • P.223 NTCP mutations manifest with neonatal cholestasis and midline defects - a new syndrome that may need liver transplant
    Dr. Rohit Kohli, United States
  • P.224 Double-balloon enteroscopy in treatment of recurrent gastrointestinal tract bleeding in patient after living related donor liver transplantation with portal hypertension – case report
    Dr. Grzegorz Kowalewski, Poland
  • P.225 Liver transplantation for acute intermittent porphyria with biallelic HMBS gene mutation
    Dr. Girish S Rao, United States
  • P.226 Combination vasodilator therapy as a bridge to successful liver transplantation in severe portopulmonary hypertension
    Dr. Girish S Rao, United States
  • P.227 The need of venous drainage reconstruction in living donor liver transplantation- case reports
    Prof. Marek Szymczak, Poland
  • P.228 Clinical impact of in vivo reduction size of donor liver in pediatric liver transplantation
    Miss Zoe Tremblay, Canada
  • P.229 The outcomes of split liver transplantation compared with living donor liver transplantation in pediatric patients
    Dr. Kyung Chul Yoon, Korea
  • P.230 Simultaneous partial splenectomy during liver transplantation in pediatric patients for prevention of persistent severe hypersplenism after liver transplantation
    Dr. Lin Wei, People's Republic of China
  • P.231 Renal function in the pediatric liver transplant patient
    Dr. Isaac Clouse, United States
  • P.232 Early referral to transplant centers is a prognostic factor influencing outcomes of pediatric liver transplantation
    Dr. Marco Spada, Italy
  • P.233 Evaluation of spleen volume with computed tomography after liver transplantation in pediatric recipients
    Prof. Figen Ozcay, Turkey
  • P.240 Prevalence of infections in infants within first six months of liver transplantation
    Prof. Figen Ozcay, Turkey
  • P.241 Burden of cytomegalovirus DNAemia among pediatric renal transplant patients on antiviral prophylaxis: A hospital-based analysis
    Dr. Upton D. Allen, Canada
  • P.242 Intravenous Human Immunoglobulin in combination with immunosuppression reduction for early onset BK viremia in pediatric kidney transplant patients
    Mrs. Jessica L Brennan, United States
  • P.243 Cytomegalovirus infection in pediatric solid organ transplant recipients and role of prophylaxis
    Dr. Gwen Nance, United States
  • P.244 Successful treatment of severe BK viremia with IVIG in a highly sensitized pediatric renal transplant recipient with concomitant reduction in donor-specific antibodies
    Dr. Kim Piburn, United States
  • P.245 Nested stromal epithelial tumor of liver colon: a case report of bone and lung metastases after liver transplant
    Dr. Emille Reyes-Santiago, United States
  • P.246 Efficacy and safety of rituximab for Epstein-Barr virus infection in pediatric organ transplantation
    Dr. Gwenaelle Roussey, France
  • P.247 Graft Nephrectomy to rescue 3 year old following early rhizipous (mucor) pyelonephritis
    Dr. Alexander H Toledo, United States
  • P.248 Oral immunoglobulin G: An underused therapy for treating refractory diarrhea in pediatric solid organ transplant
    Dr. Priya S. Verghese, United States
  • P.255 A retrospective analysis of tissue doppler velocities in pediatric heart transplant patients
    Dr. Kathryn Armstrong, Canada
  • P.256 Pediatric hypertrophic cardiomyopathy: survival and prognostic indicators in the current era
    Dr. Jenna Ashkanase, Canada
  • P.257 Technical aspects and practical considerations in treating refractory rejection in pediatric heart transplant patients with extracorporeal photopheresis
    Miss Stephanie A Church, United States
  • P.258 Clinical exercise testing in pediatric heart transplant patients: What have we learned in 20 years?
    Ms. Astrid De Souza, Canada
  • P.259 Acute Decompensation in a Heart Transplant Recipient with Multiple Co-Infections
    Dr. Jessie J Hu, United States
  • P.260 Using ventricular assist device (VAD) as bridge to myocardial recovery followed by device explantation in paediatric patients – An emerging therapeutic option for acute heart failure
    Dr. Abbas Khushnood, United Kingdom
  • P.261 Relieving bronchial compression due to cardiomegaly; the role of aortopexy when LVAD support just isn’t enough
    Dr. Jessica A Laks, Canada
  • P.262 Alloantibody Reduction in Pediatric Heart Transplant Recipients
    Brian Feingold, United States

© 2021 IPTA 2019